Henry Schein (HSIC) Tops Q1 EPS by 3c, provides guidance
Get Alerts HSIC Hot Sheet
Price: $89.52 -0.32%
Revenue Growth %: +3.9%
Financial Fact:
Diluted (in dollars per share): 1.63
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.9%
Financial Fact:
Diluted (in dollars per share): 1.63
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Henry Schein (NASDAQ: HSIC) reported Q1 EPS of $1.15, $0.03 better than the analyst estimate of $1.12. Revenue for the quarter came in at $3.17 billion versus the consensus estimate of $3.24 billion.
GUIDANCE:
Henry Schein sees FY2025 EPS of $4.80-$4.94, versus the consensus of $4.84.
2025 total sales growth is unchanged and is expected to be approximately 2% to 4% over 2024.
2025 Adjusted EBITDA3 growth is unchanged and is expected to increase mid-single digits compared with 2024.
Adjustments
For earnings history and earnings-related data on Henry Schein (HSIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: We Make A Market Buying Older Bonds
- Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James
- Jefferies on MP Materials (MP): 'Magnet Ramp Remains on Track'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share